Tags: adjuvants, biochemistry, bioengineering, immune response, immunology, vaccine design, yeastalectiniblung canceradjuvantchemotherapy
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 2 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | First Treatment Approved for Genetic Clotting Disorder - 10 months ago | |
| 3 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - about 1 month ago FDA Approves Rybrevant as First-Line Treatment for NSCLC - 7 months ago | |
| 4 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
| 5 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Tralokinumab Controls Moderate-to-Severe AD Over the Long Term - 10 months ago | |
| 6 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Up-and-comers look for an edge in the bustling ADC field - 3 months ago | |
| 7 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 8 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 9 | Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. | ||
| 10 | Kristina Fiore MedPage Today Explains healthcare complexities. Not endorsements. New York, New York |